Showing results (1-10 of 49) with videos related to
Sort By:
Pageof 5
Expert Opinion on Pharmacotherapy|December 4, 2003
Aprepitant--a novel NK1-receptor antagonistLisa Patel, Celeste LindleyJournal of the American Pharmaceutical Association (Washington, D.C. : 1996)|September 26, 2002
Developments in breast cancer therapyCeleste LindleyClinical Therapeutics|January 11, 2007
Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignanciesTed Shih, Celeste LindleyThe Annals of Pharmacotherapy|October 21, 2003
Use of NSAIDs for the chemoprevention of colorectal cancerJill M Herendeen, Celeste LindleyClinical Therapeutics|November 18, 2005
Pemetrexed: a multitargeted antifolateKristan D Rollins, Celeste LindleyJournal of Clinical Pharmacology|November 18, 2005
Bioavailability and metabolism of prochlorperazine administered via the buccal and oral delivery routeAndrew Finn, Jason Collins, Robert Voyksner, et al.Journal of Pain and Symptom Management|March 5, 2003
Is patient satisfaction a legitimate outcome of pain management?John Carlson, Richard Youngblood, Jo Ann Dalton, et al.Journal of Biochemical and Molecular Toxicology|February 10, 2009
Regulation of cytochrome P450 2C9 expression in primary cultures of human hepatocytesJasminder Sahi, Stacy S Shord, Celeste Lindley, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 2, 2003
Randomized double-blind study of the Reliefband as an adjunct to standard antiemetics in patients receiving moderately-high to highly emetogenic chemotherapyImad Treish, Stacy Shord, John Valgus, et al.Pageof 5